Skip to content

Clinical trials

Phase 3 Bronchiolitis Obliterans Syndrome trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 3 Country / region: United Kingdom Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20081
20103
20113
20122
20131
20141
20152
20171
20201
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting3
Terminated3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
Incyte Corporation3
Gilead Sciences2
AstraZeneca1
GlaxoSmithKline1
Janssen Research & Development, LLC1
Mundipharma Research GmbH & Co KG1
Newcastle University1
Novartis Pharmaceuticals1
Pharmacyclics LLC.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome20
Leukemia4
Lymphoma, Follicular4
Leukemia, Lymphocytic, Chronic, B-Cell3
Psoriasis3
Hepatitis C2
Pruritus2
Pulmonary Disease, Chronic Obstructive2
Anemia1
Bone Marrow Diseases1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.